Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EnTox Sciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
EnTox Sciences

EnTox Sciences

Pre-Seed

EnTox Sciences provides analytical tools for examining living tissue to life science and pharmaceutical sectors.

HQ
Mercer Island, WA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to support life science researchers and the pharmaceutical industry, EnTox Sciences provides advanced analytical tools designed to investigate metabolic, signaling, and secretory functions in living tissue. Their flagship product, the Barofuse, along with complementary tools like the fraction collector module, Barofuse UI, and enclosure module, addresses critical challenges in biomedical research. By offering these innovative solutions, EnTox Sciences aims to enhance the efficiency and accuracy of early-stage physiological studies.

EnTox Sciences has garnered attention for its significant contributions to the field of biomedical research. The company is backed by a team of experts in analytical instrumentation and life sciences, though specific notable individuals and investors are not detailed. Their achievements include the successful deployment of their instruments in various research settings, which has led to improved understanding of human physiology and more effective drug development processes. Overall, EnTox Sciences has made a substantial impact by providing essential tools that streamline and advance biomedical research.

EnTox Sciences - Similar Companies

Insightful Science logo

Insightful Science

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

Exum Instruments logo

Exum Instruments

Fluidigm logo

Fluidigm

standardbio.com

Entopsis logo

Entopsis

entopsis.com

Enzium logo

Enzium

enziumlabs.com

Attometrics logo

Attometrics

Isolation Sciences logo

Isolation Sciences

ProForma Labs logo

ProForma Labs

proformalabs.com

Paracelsian logo

Paracelsian

Hardin Scientific logo

Hardin Scientific

Calibre Scientific logo

Calibre Scientific

Stillwater Scientific Instruments logo

Stillwater Scientific Instruments

BioLum Sciences logo

BioLum Sciences

biolumsciences.com

AvanSci Bio logo

AvanSci Bio

avanscibio.com

EnTox Sciences - Quick Facts

Who are EnTox Sciences' competitors?

Companies similar to EnTox Sciences include Insightful Science, Thermo Fisher th, Exum Instruments and Fluidigm.

When was EnTox Sciences founded?

EnTox Sciences was founded in 2013.

Where is EnTox Sciences' headquarters located?

EnTox Sciences' headquarters is located in Mercer Island, WA, US.

When was EnTox Sciences' last funding round?

EnTox Sciences' most recent funding round was for $900k (USD) in April 2019.

How much has EnTox Sciences raised to-date?

As of Apr 25, 2019, EnTox Sciences has raised a total of $1.1M (USD).

How many employees does EnTox Sciences have?

EnTox Sciences has 6 employees as of Feb 4, 2024.

EnTox Sciences - Classification

Industry
  • Hardware
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Analytical Tools
Tags
  • Biotech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations